The information disclosure company    

DATA & CONSULTING

• Japan drug approvals
• Pricing & Reimbursement
• Japanese pharmaceutical regulations
• Pharmaceuticals & Biologicals
• Medical devices
• Quasi-drugs & Cosmetics

---

NEW SUBSCRIBERS
to Japan Approvals Databases (JAD) - click for full information

USERS AREA

---

SEARCH JKS SITES

     

Read before search

ADVANCED SEARCH

---

JAD NEWS

March 17, 2008: Introduction to JKS News

February 14, 2008: JKS News launched

October 26, 2008: JAD Databases and Drug Price List service

Jouhou Koukai Services LLC and its businesses provide information and intelligence on the Japanese pharmaceutical market in the fields of drug and medical device approval, regulatory and pharmaceutical affairs, and market data.

Company of the week:
Daiichi Sankyo KK

 

Regulatory and Commercial Headlines

JKS News: XML  RSS feed

November 12, 2008: Mid-size generics maker Aska Seiyaku KK and Iceland-based Actavis Group PTC ehf to established 55:45 shared Aska Actavis Seiyaku KK in Tokyo in 2009 for manufacturing and sales of generics from 2010 ... Aska products in JAD Databases  |   Report preview
November 10, 2008: M&A research provider Recof KK survey: the value of Japanese M&A during Jan-Oct period increased 3.7 times compared to 2007 ... related readings
November 7, 2008: JKS News: Daiichi-Sankyo KK finalized the acquisition of Ranbaxy Laboratories Ltd (RLL) thus becoming the world 15th largest pharma company ... Daiichi Sankyo products in JAD Databases
November 6, 2008: Mr. Isao Teshirogi , President of Shionogi Seiyaku KK quoted as predicting size reduction of US pharma market as consequence of election results ... Market consulting
October 31, 2008: JKS News: Sanofi-aventis KK to start dissolving pre-deregulation era pharma joint ventures, starting with Laboratoires Daiichi Sanofi-aventis and Sanofi-aventis Daiichi Seiyaku KK, established in 1989 for anti-thrombotic treatment; other JV may follow ... Sanofi in JAD Databases
October 30, 2008: Fukushima Medical University Hospital reported to accept patients donations to bypass the ban on mixed insurance payment for high-expense treatment; the case likely to result in review of the regulations ... Reimbursement consulting | Report preview
October 28, 2008: Novartis AG Chairman and CEO Daniel Vasella told the 10th Nikkei Global Management Forum in Tokyo that the company has enough "innovation and brainpower" for robust drug development ... Novartis products in JAD Databases

...more headline news

DOCUMENTS STORE

Japan Master Files - view

Accredited Foreign Manufacturers preview

Japan Orphan Drugs
preview

Japan Pricing & Reimbursement preview

Japanese Generics and API
preview

Stigmatized Markets: ED
preview

Stigmatized Markets: Depression preview

Stigmatized Markets: Genital Herpes preview

Stigmatized Markets: Metabolic Syndrome preview

Unapproved Medicinal Products (drug lag) preview

Vaccines and Sera (vaccine gap) preview

IN THE MEDIA

EContent Magazine: Jouhou Koukai Adds to Database

JOBS

"At present we are looking for individuals with diversified expertise in content creation and management, database development, micro-content and rich data." For further details click here.

JKS, HR Department